Regeneron Pharmaceuticals
REGN
#288
Rank
C$106.88 B
Marketcap
C$1,008
Share price
-0.12%
Change (1 day)
-4.59%
Change (1 year)

Market capitalization of Regeneron Pharmaceuticals (REGN)

Market cap: C$106.88 Billion

As of December 2025 Regeneron Pharmaceuticals has a market cap of C$106.88 Billion. This makes Regeneron Pharmaceuticals the world's 288th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regeneron Pharmaceuticals from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025C$106.88 B-4.85%
2024C$112.33 B-11.49%
2023C$126.91 B19.04%
2022C$106.61 B23.18%
2021C$86.55 B31.68%
2020C$65.73 B21.54%
2019C$54.07 B-2.49%
2018C$55.46 B9.21%
2017C$50.78 B-2.39%
2016C$52.02 B-33.98%
2015C$78.80 B61.6%
2014C$48.76 B66.96%
2013C$29.20 B76.47%
2012C$16.55 B217.08%
2011C$5.21 B77.87%
2010C$2.93 B42.21%
2009C$2.06 B16.05%
2008C$1.77 B-6.4%
2007C$1.89 B24.31%
2006C$1.52 B46.28%
2005C$1.04 B69.08%
2004C$0.61 B-41.72%
2003C$1.06 B-18.51%
2002C$1.30 B-34.03%
2001C$1.97 B1.45%
2000C$1.94 B236.42%
1999C$0.57 B64.29%
1998C$0.35 B-7.03%
1997C$0.37 B-33.29%
1996C$0.56 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Regeneron Pharmaceuticals was reported to be:

C$105.98 Billion
by Nasdaq info icon info icon
C$106.88 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
C$255.56 B 139.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$85.77 B-19.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$37.24 B-65.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$680.64 B 536.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$354.53 B 231.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$166.53 B 55.81%๐Ÿ‡ซ๐Ÿ‡ท France